Home » Topics » Disease categories and therapies » Inflammatory

Inflammatory
RSS

Galapagos presents new sphingosine 1-phosphate receptor antagonists

Sep. 19, 2017

Novartis identifies potent, irreversible myeloperoxidase inhibitors for inflammation

Sep. 19, 2017

FDA issues complete response letter for Ryanodex

July 27, 2017

Unity Biotechnology patents Bcl-W, Bcl-XL and Bcl-2 inhibitors

July 12, 2017

GlaxoSmithKline describes novel CPHPC prodrugs

May 24, 2017

FDA grants priority review to Ryanodex NDA to treat exertional heat stroke

March 28, 2017

Santen Pharmaceutical patents glucocorticoid receptor agonists

March 24, 2017

Mouse model developed for the study of alpha-gal meat allergy

March 14, 2017

TiGenix initiates phase Ib/IIa trial of Cx-611 to treat sepsis in community-acquired pneumonia

Jan. 31, 2017

Eagle Pharmaceuticals completes NDA submission for Ryanodex

Jan. 24, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...